demonstrated a slight increase in lesion size and enhancement as compared to the previous exam ( Figure 1 ). Again, no hydrocephalus could be appreciated and she remained relatively asymptomatic. However, over the next two months she had two episodes of severe morning headache, nausea and vomiting and developed limited upward gaze. On examination there was a right-beating nystagmus and difficulty in tandem gait. An MRI demonstrated further growth of the fourth ventricular lesion, measuring 2.6 x 2.4 x 2.3 cm (Figure 1 ). She was started on oral corticosteroids and underwent urgent resection of the lesion after she deteriorated, developing weakness of the lower limbs, visual blurring, headache, photophobia and left upper limb dysmetria. A midline occipital craniectomy was performed allowing access to the foramen of Magendie where the tumor was visualized. The tan grey tumor arose from the floor of the fourth ventricle and infiltrated the roof of the ventricle. There was obvious tumour seeding of the adjacent ventricle and cerebellum. Complete gross resection of the highly vascular tumor was not possible. Postoperative examination revealed a dense left facial palsy, loss of left lateral gaze, normal trigeminal function and a positive left Bell's reflex. The patient developed a small left corneal abrasion, so her left eyelid was fitted with a gold weight. An MRI prior to discharge demonstrated residual tumor in the fourth ventricle ( Figure 2 ) and a small nodule attached to the ventral medulla ( Figure 3 ).
Surgical Pathology
The tumour was moderately to highly cellular arranged in patternless sheets with delicate, profuse vascular supply (Figure 4 ). Cells possessed pale eosinophilic cytoplasm with delicate processes and vascular proliferation. Cell nuclei were monomorphic and round with delicate salt and pepper chromatin pattern. Mitotic activity was not observed and there was limited, but demonstrable perinuclear halo effect.
Immunohistochemical staining revealed irregular vasculature on reticulin staining, strong positive staining for neuron-specific enolase, and negative staining for synaptophysin, neurofilament and glial fibrillary acidic protein (Figure 4 ). Ultrastructural analysis revealed occasional Golgi apparati and few electron dense bodies. Processes were short and stubby containing mitochondria, vesicles and endoplasmic reticulum. However, no specific synaptic vesicles or intermediate 
Figure 1: Serial Gadolinium enhanced T1 images of the fourth ventricular lesion. Images correspond to tumour appearance at presentation (A), at 5 months following presentation (B), 10 months following presentation (C) and postoperatively (D). The mass is heterogeneously enhancing throughout but gains signal with progression. There is distension of the fourth ventricle as the lesion progresses and increases in size.

Figure 2: Postoperative gadolinium enhanced T1 weighted MRI images depicting incomplete resection of the fourth ventricular tumour. In both the coronal (A) and axial (B) images there is a rim of enhancement surrounding the area previously occupied by tumour.
There is no evidence of additional tumour elsewhere in the ventricular system.
Figure 3: Postoperative gadolinium enhanced T1 weighted MRI images of the cervical spinal cord depicting a nodule of heterogeneously enhancing tissue on the ventral surface of the medulla. Arrows in the sagittal (A) and axial (B) images depict the anterolateral, right sided, location of the nodule which may correspond to disseminated disease.
filament bundles were seen. There were no intercellular junctions and no synapses noted. Final diagnosis was central neurocytoma. Ki-67 immunohistochemistry was performed on all submitted tissue. Rare foci showed 1-2% positive nuclei, but most areas had below 1% Ki-67 immunopositivity; the consistency of labeling mitigates against the possibility that the tumour was insufficiently sampled. This is entirely in keeping with neurocytoma, and mitigates against a more sinister lesion. The lack of synaptophysin immunopositivity is unusual, but is supported by the absence of neurosecretory granules on electron microscopy.
Radiation Therapy and Follow-up
The patient experienced a period of severe depression which required psychiatric admission and delayed the start of radiation therapy. In view of the spinal cord seeding, radiation was initially administered to the whole of the craniospinal axis: 3600 cGy were delivered in 18 fractions over 3.5 weeks, with 6MV photons. This was followed by a boost dose to the tumour bed and upper cervical spine of a further 2000 cGy in 10 fractions over two weeks. During the treatment she continued to require treatment of headache, nausea and vomiting. On review four months later these symptoms had abated and MRI showed improvement in the degree of enhancement of the residual tumour as well as disappearance of the lesion on the ventral medulla ( Figure 5 ).
DISCUSSION
Since the original description of central neurocytoma there have been several hundred cases reported. The present case displays several unusual findings for CN. Neurocytoma of the fourth ventricle is rare. We could find only two prior case reports. 18, 19 Both of these cases presented with obstructive hydrocephalus requiring immediate surgical treatment. Our patient initially had mild symptomatology and was not offered early intervention. However, the patient demonstrated gradual onset and worsening of obstructive symptomatology. Steroids prescribed over a three week period before the acute presentation leading to surgery were of no apparent benefit.
Our patient presented late in her sixth decade. Central neurocytoma classically arises in younger people; however, there are reports of people presenting with CN in their sixth and seventh decade. 11, [20] [21] [22] [23] In terms of prognosis, a late age of onset has been shown to be a negative predictor of outcome. 8 In this case, the appearance of the tumor on MRI fit the classic description of neurocytoma. 1, 7, 8, 10 The tumour was well demarcated, heterogeneously enhancing and possessed evidence of calcification. On surgical resection the tumor was found to be highly vascular. This is similar to the tumors described in the surgical case series by Yasargil. 4 The local spread observed in our case was atypical for CN. This pattern was reminiscent of the seeding observed in medulloblastoma. The resection was incomplete and enhancing tissue and seeding were observed on postoperative imaging. These findings suggest that our patient has a malignant variant of CN. A case of CN that recurred with a highly malignant phenotype and associated seeding throughout
Figure 4: (A) Histology demonstrates hypercellular tissue with homogeneous round to ovoid cells arranged in non-descript sheets, slightly eosinophilic cytoplasm and salt and pepper chromatin patterning of the nuclei. (B) Smear sample demonstrates delicate processes. (C) There was some perinuclear clearing which is characteristic of this lesion. (D) Neuron specific enolase immunohistochemistry is strongly positive. Neurofilament, synaptophysin and glial fibrillary acidic protein staining were absent in the tumour sample (not depicted).
Figure 5: Gadolinium enhanced T1 images of the fourth ventricle. Coronal (A) and axial (B) images demonstrate significantly diminished enhancement of the fourth ventricular lesion. The enhancing nodule located on the ventral medulla had resolved at the time of this MRI (not shown).
the ventricular system was reported by Elek et al. 24 Aggressive CN with diffuse craniospinal dissemination has also been described in three additional cases. 2 4 -2 6 Less likely is an associated tumor, as in the case of right lateral ventricular CN associated with fourth ventricular medulloblastoma. 2 7 T h e authors of this case suggest a common etiology in erroneous differentiation of granular cerebellar and ventricular progenitor cells that perpetuated the medulloblastoma and neurocytoma respectively. Although direct evidence to this effect is not available it is possible that our patient could harbor a similar lesion or a variant lesion with malignant properties.
The pathological differential diagnosis in the present case includes: (i) clear cell ependymoma (however no morphological, immunohistochemical or ultrastructural evidence of ependymal differentiation was detected), (ii) cerebellar liponeurocytoma, an indolent variant of medulloblastoma (this would require the identification of lipid in neoplastic cells which was absent in the present case, although limited sampling precludes ruling out this possibility entirely), (iii) the rosette forming and papillary glioneuronal tumours; these have distinct features which were absent in our case, and should exhibit distinct GFA P immunopositivity, which was not seen, and (iv) clear cell variants of meningioma and metastatic carcinoma (these were rejected on morphological grounds).
Chemotherapy has been used in recurrent disease in a few patients with equivocal outcomes. 28, 29 Stereotactic radiosurgery is being explored and has been used with good early results in recurrent/progressive CN. 30, 31 Radiation has not been shown to statistically improve survival outcomes following incomplete resection, but has been shown to give significant local control of disease in the few studies completed to date. [32] [33] [34] This may be due to the well-differentiated, indolent growth properties of CN which hypothetically make it less vulnerable to ionizing radiation. However, radiation is recommended when variant disease with a malignant phenotype is suspected or demonstrated. 4 Therefore, our patient was treated secondarily with radiation. The Ki-67 index in this tumour was low suggesting that sampling was adequate. It is possible that the tumour may behave less aggressively than would be predicted on the basis of neuroimaging and intraoperative findings. However, there has been limited follow-up in this case.
Synaptophysin staining is considered the most specific immunohistochemical marker for CN. 11 However, in this case, synaptophysin was negative while all of the other histological, immunohistochemical and ultrastructural studies were in support of CN. There have been reports of CN without synaptophysin expression. 8, 20, 35, 36 There have also been reports of technical limitations in synaptophysin staining that may yield falsenegative results. 8, 11 However, it has been shown that, in primitive neuroectodermal tumors, synaptophysin is expressed after neuron specific enolase and before neurofilament in the spectrum of differentiation from progenitor to neuronal phenotype. 37 Central neurocytoma may arise from the same subependymal cell lineage as primitive neuroectodermal tumors, and this process would therefore be paralleled in CN. 2 3 Therefore, the tumor reported here may represent uniform d i fferentiation of a CN at a stage prior to synaptophysin expression. There is one patient reported from a surgical series that originally had a synaptophysin negative CN resected and then had a recurrence with a synaptophysin positive CN. 20 This observation supports the idea of the tumor progressing to express synaptophysin in the late stages of differentiation. The cellular origin of CN is controversial. It was originally proposed that CN arose from the granular layer of the small gray nuclei of the septum pellucidum. 1 , 8 This hypothesis was based on the anatomical association of CN with the wall of the lateral ventricle. Current evidence now supports the neural progenitor cells of the adult subependymal layer as the histogenic source for these tumours. 23, 36, 38, 39 The subventricular zone persists into adulthood and remains active.
4 0 -4 2 It is implicated in the production of the progenitor cells of the rostral migratory stream and generation of olfactory interneurons. 43, 44 Proliferation in the ependymal layers of the spinal cord following injury has been described. 45, 46 There is also evidence that progenitor cells exist throughout the ventricular system of the entire neuraxis in rodent models. [47] [48] [49] It is not yet clear whether these cells originate directly from the ependyma or arise in the subventricular zone or an as yet undescribed germinal center and migrate along the ependyma throughout the ventricular system. 50 Regardless, it is plausible that CN may arise at any point in the ventricular system in either scenario. One would expect to rarely observe tumors outside of the lateral ventricle as the concentration of progenitor cells is significantly lower away from the subventricular zone. 47 Supporting the ependymal progenitor hypothesis, CN has been observed arising from the ependymal component of a cystic ovarian teratoma. 51 In rodent transplantation studies, progenitor cells have been observed to invade and persist intraparenchymally. [52] [53] [54] These findings support a subependymal source for extraventricular CN by demonstrating the property of progenitor cells to invade nervous tissue. Hence, one explanation for the rare reports of cerebral, cerebellar and spinal neurocytoma is the case where a progenitor cell invades nervous tissue at any level in the ventricular system and proliferates as CN. Neural progenitor cells of the subependymal plate have been shown to be bipotential, generating glia and neurons. [55] [56] [57] [58] [59] There have been several reports of CN with both synaptophysin and GFAP immunoreactivity. 10, 23 When neurocytoma cells are cultured, d i fferentiation to a strongly GFA P positive phenotype occurs. 6 0 -6 2 A bipotential progenitor would account for this variation in marker expression in CN and fits with a subependymal or similar proliferative zone source.
This case demonstrates the rare occurrence of CN arising from the floor of the fourth ventricle. Serial imaging over a ten month period demonstrated slow growth and associated changes in tumor enhancement during this period. The management of this case was complicated by its location and vascularity. Moreover, the appearance of the tumor was suspicious for an invasive variant of CN. In this case radiation was used in an attempt to control local progression of disease and prevent further craniospinal dissemination.
